These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 546338)

  • 21. [Comparative studies on the antithrombotic effect of acetylsalicylic acid and anticoagulants on an experimental model of thrombosis].
    Zimmermann R; Zieboll L; Barth P; Lange D
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1946-7. PubMed ID: 1030144
    [No Abstract]   [Full Text] [Related]  

  • 22. Experimental thrombolysis by perfusion. II. Comparative study on the effect of streptokinase, urokinase and plasmin.
    Egeblad K; Bertelsen S
    Acta Chir Scand; 1969; 135(6):486-90. PubMed ID: 4244115
    [No Abstract]   [Full Text] [Related]  

  • 23. In vivo models for the evaluation of antithrombotics and thrombolytics.
    Mousa SA
    Methods Mol Biol; 2010; 663():29-107. PubMed ID: 20617414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental pharmacology of hirunorm: a novel synthetic peptide thrombin inhibitor.
    Cirillo R; Lippi A; Subissi A; Agnelli G; Criscuoli M
    Thromb Haemost; 1996 Sep; 76(3):384-92. PubMed ID: 8883275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
    Kanayama T; Kimura Y; Iseki K; Hayashi Y; Tamao Y; Mizogami S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1210-7. PubMed ID: 1702154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of antithrombotic agents evaluated in a nonhuman primate vascular shunt model.
    Mason RG; Wolf RH; Zucker WH; Shinoda BA; Mohammad SF
    Am J Pathol; 1976 Jun; 83(3):557-68. PubMed ID: 820202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antithrombotic effects of carrot filtrates in rats and mice.
    Yamamoto J; Naemura A; Ijiri Y; Ogawa K; Suzuki T; Shimada Y; Giddings JC
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):785-92. PubMed ID: 19002045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low molecular weight heparins: are they different?
    Fareed J; Hoppensteadt D; Jeske W; Clarizio R; Walenga JM
    Can J Cardiol; 1998 Aug; 14 Suppl E():28E-34E. PubMed ID: 9779031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinico-biological effectiveness of triflusal during the postoperative period of patients with chronic ischemic syndrome of the extremities].
    Arcas R; Herreros J; Rocha E; Honorato J; Aranza Perea J
    Rev Med Univ Navarra; 1981 Jun; 25(2):51-5. PubMed ID: 7339763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prophylactic and curative effects of a thrombolytic enzyme on experimental thrombosis and pulmonary embolism].
    Li SQ; Li LX; Wang ZC
    Zhonghua Wai Ke Za Zhi; 1986 Sep; 24(9):554-7, 575. PubMed ID: 3582048
    [No Abstract]   [Full Text] [Related]  

  • 31. Antithrombotic effect of clopidogrel in a vena cava thrombosis model in obese mice.
    Lijnen HR; Helsen S; Hoylaerts MF
    Thromb Res; 2009 Mar; 123(5):763-4. PubMed ID: 18986687
    [No Abstract]   [Full Text] [Related]  

  • 32. Antithrombotic potential of GW813893: a novel, orally active, active-site directed factor Xa inhibitor.
    Abboud MA; Needle SJ; Burns-Kurtis CL; Valocik RE; Koster PF; Amour AJ; Chan C; Brown D; Chaudry L; Zhou P; Patikis A; Patel C; Pateman AJ; Young RJ; Watson NS; Toomey JR
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):66-71. PubMed ID: 18645410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombotic and thrombolytic activity of heparins in a rat model of laser-induced thrombosis.
    Krupiński K; Giedrojć J; Breddin HK; Bielawiec M
    Pol J Pharmacol; 1996; 48(3):345-50. PubMed ID: 9112675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current treatment for thrombotic diseases.
    Cazenave JP; Wiesel ML; Hemmendinger S
    Agents Actions Suppl; 1984; 15():24-49. PubMed ID: 6091424
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibitory effect of piracetam on platelet-rich thrombus formation in an animal model.
    Stockmans F; Deberdt W; Nyström A; Nyström E; Stassen JM; Vermylen J; Deckmyn H
    Thromb Haemost; 1998 Jan; 79(1):222-7. PubMed ID: 9459351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparin.
    Tapparelli C; Metternich R; Gfeller P; Gafner B; Powling M
    Thromb Haemost; 1995 Apr; 73(4):641-7. PubMed ID: 7495072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carrageenin-induced thrombosis in rats and mice: a model for testing antithrombotic substances?
    Bekemeier H; Hirschelmann R; Giessler AJ
    Agents Actions; 1985 Jul; 16(5):446-51. PubMed ID: 4050621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental production of pulmonary granulomas. IV. Eosinophilic granuloma.
    Hamamoto Y; Kinoshita K; Hashimoto K; Matsushita T; Kogishi K; Yasuhira K
    Br J Exp Pathol; 1983 Apr; 64(2):177-84. PubMed ID: 6849813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arachidonate-induced thrombosis in mice: effects of gender or testosterone and estradiol administration.
    Uzunova AD; Ramey ER; Ramwell PW
    Prostaglandins; 1977 May; 13(5):995-1002. PubMed ID: 866707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic "in vivo" effects of quercetin 3,7,3',4'-tetrasulfate isolated from Flaveria bidentis in an experimental thrombosis model in mice.
    Guglielmone HA; Agnese AM; Nuñez-Montoya SC; Cabrera JL; Cuadra GR
    Thromb Res; 2020 Nov; 195():190-192. PubMed ID: 32736207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.